Due to the enormous potential, research with and on CAR-T cells is gaining momentum. In this article, we dive into the basics and latest developments to give you a comprehensive insight into CAR-T research. Find out how CAR-T cells are opening up new horizons in medicine with their important role in immunotherapy. With BPS Bioscience as our trusted supplier, we are here to support you with the latest tools to drive the future of CAR-T research.
Find out more about the new platform of functionalized, buoyant microbubbles from our partner Akadeum Life Sciences, that enables easy, buoyancy-driven isolation of cells. Akadeum's floating solutions overcome the disadvantages of other technologies that limit your progress or productivity - using science so simple, it floats!
A key player in so-called RNA editing is the protein ADAR1 ("adenosine deaminase acting on RNA"), an RNA-specific adenosine deaminase that catalyzes the conversion of adenosine nucleoside building blocks to inosine. Mutations in the adar1 gene are associated with a variety of diseases, so the protein may be a promising target for various therapies.
Even after Halloween, things stay bloody at Biomol - with our new partner Research Donors! The UK-based company specializes in the distribution of fresh, highly characterized human blood products. Find out what's behind the company, how sample collection and processing work, and what types of products are available in Research Donors' lineup in our new blog post!
Cancer immunotherapy seeks to use the many components of the immune system to attack cancer cells.
The amplitude and quality of the immune response of T cells is controlled by an equilibrium between costimulatory and inhibitory signals, called immune checkpoints.